TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $149,026 | -66.4% | 17,826 | -0.1% | 0.00% | -100.0% |
Q2 2023 | $443,319 | +88.0% | 17,847 | +13.8% | 0.00% | 0.0% |
Q1 2023 | $235,767 | +16.4% | 15,676 | -8.5% | 0.00% | 0.0% |
Q4 2022 | $202,636 | +132.9% | 17,129 | +16.6% | 0.00% | – |
Q3 2022 | $87,000 | +35.9% | 14,686 | -1.9% | 0.00% | – |
Q2 2022 | $64,000 | -72.3% | 14,963 | -38.4% | 0.00% | – |
Q1 2022 | $231,000 | -57.0% | 24,295 | -14.1% | 0.00% | -100.0% |
Q4 2021 | $537,000 | -1.8% | 28,297 | +72.2% | 0.00% | -50.0% |
Q3 2021 | $547,000 | -57.6% | 16,428 | -50.6% | 0.00% | -50.0% |
Q2 2021 | $1,290,000 | -17.8% | 33,256 | +2.2% | 0.00% | -20.0% |
Q1 2021 | $1,569,000 | +18.1% | 32,545 | +27.4% | 0.01% | 0.0% |
Q4 2020 | $1,328,000 | +264.8% | 25,538 | +87.6% | 0.01% | +150.0% |
Q3 2020 | $364,000 | +42.2% | 13,613 | +3.7% | 0.00% | +100.0% |
Q2 2020 | $256,000 | +96.9% | 13,128 | +12.4% | 0.00% | 0.0% |
Q4 2019 | $130,000 | +21.5% | 11,682 | +2.1% | 0.00% | 0.0% |
Q2 2014 | $107,000 | -1.8% | 11,442 | -27.3% | 0.00% | 0.0% |
Q1 2014 | $109,000 | – | 15,738 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |